Most people do not use one drug, but many. SUDs often involve different substances, but the underlying problem is really one ...
Weekly injections of the GLP-1 semaglutide reduce alcohol consumption in patients with obesity seeking treatment for alcohol ...
When danger lurks, instinct keeps us safe. It compels us to run from a burning building or wrestle a knife-wielding attacker ...
Ozempic can help people who are battling alcoholism, a major new clinical trial has concluded. People with alcohol use ...
Early-stage studies of medications to treat high-risk alcohol use may be missing opportunities to identify potential ...
No matter what’s ailing you, exercise seems to help. Ample research shows that regular workouts improve a multitude of conditions, imparting physical and psychological benefits. Now, a new paper ...
Clearmind Medicine Inc. (Nasdaq: CMND) ('Clearmind” or the 'Company'), a clinical-stage biotech company focused on the discovery and development of novel, non-hallucinogenic, second generation, ...
For people trying to reduce their heavy drinking, the quality of their interpersonal relationships early in their recovery ...
Everyday Health on MSN
Could Ozempic and other GLP-1 drugs treat alcohol use disorder?
Mounting research suggests GLP-1 drugs, which are used to treat diabetes and obesity, may one day help people with alcohol ...
In 2003, Wendy Dossett chaired an international symposium at a UK university. “I don’t remember chairing it. I know that I did, but I don’t remember anything that happened,” she says. At the time, she ...
Once-weekly semaglutide was tied to a reduction in heavy drinking days among adults with obesity and alcohol use disorder, ...
MCV is a measurement of red blood cells. Scientists have established the link between MCV and alcohol use, as large quantities of alcohol can enlarge the red blood cells. Mean corpuscular volume (MCV) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results